Fonti R - Search Results

1

Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patients.

Pace L, Klain M, Salvatore B, Nicolai E, Zampella E, Assante R, Pellegrino T, Storto G, Fonti R, Salvatore M. Pace L, et al. Among authors: fonti r. Clin Nucl Med. 2015 Feb;40(2):111-5. doi: 10.1097/RLU.0000000000000621. Clin Nucl Med. 2015. PMID: 25546215

2

Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography.

Li PY, Del Vecchio S, Fonti R, Carriero MV, Potena MI, Botti G, Miotti S, Lastoria S, Menard S, Colnaghi MI, Salvatore M. Li PY, et al. Among authors: fonti r. J Nucl Med. 1996 Apr;37(4):665-72. J Nucl Med. 1996. PMID: 8691264 Free article.

3

Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy.

Catalano L, Pace L, Califano C, Pinto AM, De Renzo A, Di Gennaro F, Del Vecchio S, Fonti R, Salvatore M, Rotoli B. Catalano L, et al. Among authors: fonti r. Haematologica. 1999 Feb;84(2):119-24. Haematologica. 1999. PMID: 10091409 Clinical Trial.

4

Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma.

Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Di Gennaro F, Catalano L, Califano C, Pace L, Rotoli B, Salvatore M. Fonti R, et al. Eur J Nucl Med. 2001 Feb;28(2):214-20. doi: 10.1007/s002590000434. Eur J Nucl Med. 2001. PMID: 11303893 Clinical Trial.

5

Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients.

Del Vecchio S, Zannetti A, Ciarmiello A, Aloj L, Caracò C, Fonti R, Botti G, D'Aiuto G, Salvatore M. Del Vecchio S, et al. Among authors: fonti r. Eur J Nucl Med Mol Imaging. 2002 Jun;29(6):809-14. doi: 10.1007/s00259-002-0773-x. Epub 2002 Mar 13. Eur J Nucl Med Mol Imaging. 2002. PMID: 12029556

6

Sentinel lymph node identification in breast cancer patients.

Fonti R, Limite G, Sodano A, Riccardi A, Forestieri P, De Cristofaro G, Pettinato G, Salvatore M. Fonti R, et al. Radiol Med. 2002 Apr;103(4):370-7. Radiol Med. 2002. PMID: 12107387 English, Italian.

7

New frontiers of nuclear medicine.

Salvatore M, Fonti R. Salvatore M, et al. Among authors: fonti r. Tumori. 2002 May-Jun;88(3):S60-1. doi: 10.1177/030089160208800350. Tumori. 2002. PMID: 12369559 No abstract available.

8

Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma.

Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Catalano L, Pace L, Rotoli B, Salvatore M. Fonti R, et al. Cancer Biother Radiopharm. 2004 Apr;19(2):165-70. doi: 10.1089/108497804323071931. Cancer Biother Radiopharm. 2004. PMID: 15186596 Clinical Trial.

9

Washout of [99mTc] sestamibi in predicting response to chemotherapy in patients with multiple myeloma.

Pace L, Catalano L, Del Vecchio S, De Renzo A, Fonti R, Salvatore B, Andretta C, Di Nuzzo C, Rotoli B, Salvatore M. Pace L, et al. Among authors: fonti r. Q J Nucl Med Mol Imaging. 2005 Sep;49(3):281-5. Q J Nucl Med Mol Imaging. 2005. PMID: 16172574 Free article. Clinical Trial.

10

Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis.

Catalano L, Del Vecchio S, Petruzziello F, Fonti R, Salvatore B, Martorelli C, Califano C, Caparrotti G, Segreto S, Pace L, Rotoli B. Catalano L, et al. Among authors: fonti r. Ann Hematol. 2007 Jun;86(6):415-23. doi: 10.1007/s00277-007-0263-0. Epub 2007 Feb 7. Ann Hematol. 2007. PMID: 17285274 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters